Baxter's CDMO arm will add 100 new positions in $50M fill-finish expansion of Indiana plant

In recent months, the contract manufacturing market has seen a wave of investment in the U.S. amid the COVID-19 pandemic and a call for "onshore" drug production. Now, Baxter's CDMO arm is stepping up to the plate with a finishing technology expansion at its Indiana site.